Echocardiographic Variable | COVID-19 ARDS survivors (n = 56)a | COVID-19 ARDS non-survivors (n = 120) | ||||
---|---|---|---|---|---|---|
Admission | Day 10 | p value | Admission | Day 10 | p value | |
Age, years | 65.9 ± 1.5 |  |  | 67.4 ± 1.0 |  |  |
Sex, % | 39 (69.6%) | Â | Â | 80 (66.7%) | Â | Â |
APACHE II score | 16.2 ± 0.9 |  |  | 17.3 ± 0.7 |  |  |
SOFA score | 7.5 ± 0.2 |  |  | 8.05 ± 0.2 |  |  |
Right ventricle | ||||||
 RVEDA/LVEDA | 0.8 ± 0.05 (49) | 0.6 ± 0.03 (49)# | 0.001 | 0.81 ± 0.03 (78) | 0.89 ± 0.03 (78) | 0.864 |
 ACP | 12 (24.5) | 5 (10.2) | 0.073 | 21 (26.9) | 14 (17.9) | 0.850 |
 RVEDA, cm2 | 22.1 ± 0.6 (49) | 17.8 ± 0.8 (49)* |  < 0.0001 | 23 ± 0.8 (78) | 24.4 ± 0.8 (78) | 0.097 |
 RVESA, cm2 | 14.1 ± 0.5 (49) | 10.3 ± 0.5 (49)# |  < 0.0001 | 14.5 ± 0.6 (78) | 15.2 ± 0.8 (78) | 0.357 |
 RV FAC, % | 37.4 ± 1.6 (49) | 41.1 ± 1.9 (49) | 0.073 | 35.9 ± 1.6 (78) | 38.9 ± 1.7 (78) | 0.253 |
 RVEDVb, ml | 128.1 ± 13.9 (29)* | 92.8 ± 8.4 (29)* | 0.006 | 110.91 ± 6.02 (44) | 121.3 ± 6.17 (44) | 0.004 |
 RVESVb, ml | 82.4 ± 10.2 (29)* | 52.2 ± 5.3 (29)* | 0.002 | 67.6 ± 3.9 (44) | 73.6 ± 4.4 (44) | 0.127 |
 RVEFb (%) | 36.5 ± 2.9 (29) | 46.6 ± 2.1 (29)* | 0.001 | 38.8 ± 1.5 (44) | 39.1 ± 2 (44) | 0.916 |
 TAPSE, mm | 19.8 ± 0.6 (51) | 21.5 ± 0.5 (51) | 0.008 | 20.3 ± 0.6 (73) | 22 ± 2 (73) | 0.404 |
 RV S’, cm/sec | 16.8 ± 0.8 (53) | 19.9 ± 0.7 (53)# | 0.002 | 15.3 ± 0.6 (74) | 14.1 ± 0.5 (74) | 0.045 |
 RV IVA, m/sec2 | 3.98 ± 0.17 (53) | 4.1 ± 0.17 (53) | 0.318 | 3.66 ± 0.12 (74) | 3.77 ± 0.14 (74) | 0.260 |
 RV–LS, % | − 13.6 ± 0.7 (42) | − 16.7 ± 0.8 (42)# | 0.001 | − 14.3 ± 0.8 (64) | − 12.6 ± 0.5 (64) | 0.017 |
 VTIRVOT, cm | 17 ± 0.7 (41) | 19.4 ± 0.5 (41)# | 0.011 | 16.2 ± 0.5 (60) | 16.1 ± 0.4 (60) | 0.987 |
 PASP, mmHg | 36.1 ± 2.4 (43) | 20.1 ± 3 (43)# |  < 0.0001 | 34.9 ± 1.8 (66) | 36.3 ± 1.1 (66) | 0.347 |
 PASP/VTILVOT, mmHg/cm | 2 ± 0.2 (43) | 0.9 ± 0.1 (43)# |  < 0.0001 | 2 ± 0.2 (65) | 1.9 ± 0.1 (65) | 0.543 |
 PASP/VTIRVOT, mmHg/cm | 2.5 ± 1.4 (34) | 1.1 ± 0.7 (34)# |  < 0.0001 | 2.5 ± 1.5 (57) | 2.4 ± 0.9 (57) | 0.445 |
 Pulmonary AcT, msec | 61 ± 2.5 (41) | 84.7 ± 2.4 (41)# |  < 0.0001 | 66.8 ± 2.6 (60) | 62.6 ± 2.3 (60) | 0.096 |
 RVOT notch | 15 (23.4%) | 4 (6.3%) * | 0.033 | 21 (35%) | 13 (21.6%) | 0.321 |
 VACR, mm/mmHg | 0.80 ± 0.1 (43) | 1.5 ± 0.1 (43)# |  < 0.0001 | 0.73 ± 0.07 (60) | 0.66 ± 0.08 (60) | 0.497 |
Left ventricle | ||||||
 LVEDD, mm | 4.66 ± 0.1 (49) | 4.62 ± 0.1 (49) | 0.576 | 4.55 ± 0.06 (78) | 4.53 ± 0.06 (78) | 0.760 |
 IVS, mm | 0.9 ± 0.01 (49) |  |  | 0.92 ± 0.01 (78) |  |  |
 LVEDA, cm2 | 27.2 ± 1.03 (49) | 27.1 ± 0.8 (49) | 0.917 | 29.2 ± 0.7 (78) | 27.9 ± 0.7 (78) | 0.097 |
 LVESA, cm2 | 17.4 ± 2.2 (49) | 15.9 ± 1.5 (49) | 0.555 | 16.3 ± 1.9 (78) | 12.8 ± 1.2 (78) | 0.357 |
 VTILVOT, cm | 19.9 ± 0.1 (49) | 21.8 ± 0.5 (49)* | 0.005 | 20.2 ± 0.7 (78) | 20.1 ± 0.5 (78) | 0.914 |
 LVEDV, ml (2D) | 81.5 ± 4.5 (49) | 85.9 ± 3.2 (49) | 0.441 | 85.5 ± 4.9 (78) | 80.7 ± 3.1 (78) | 0.361 |
 LVESV, ml (2D) | 30.1 ± 2.5 (49) | 32.1 ± 1.9 (49) | 0.535 | 35.4 ± 3.8 (78) | 32.5 ± 2 (78) | 0.409 |
 EF, % | 62.5 ± 2.6 (49) | 62.2 ± 2.8 (49) | 0.932 | 60.4 ± 2.3 (78) | 59.9 ± 1.7 (78) | 0,869 |
 SV, ml (Simpson’s) | 50.1 ± 3.1 (49) | 53.1 ± 2.7 (49) | 0.600 | 47.6 ± 3.2 (78) | 47.9 ± 2 (78) | 0.754 |
 LVEDV, ml (3D)b | 82.5 ± 3.6 (30) | 84.6 ± 2.8 (30) | 0.553 | 82 ± 3.6 (42) | 85.1 ± 3 (42) | 0.187 |
 LVESV, ml (3D)b | 32.1 ± 1.9 (30) | 34.5 ± 1.7 (30) | 0.266 | 35 ± 2.2 (42) | 35.3 ± 2 (42) | 0.857 |
 SV, ml (3D)b | 50.3 ± 2.5 (30) | 50.1 ± 2.5 (30) | 0.952 | 46.9 ± 2.2 (42) | 49.8 ± 2.1 (42) | 0.221 |
 EF (3D), %b | 61.1 ± 1.5 (30) | 58.6 ± 2.1 (30) | 0.356 | 57.4 ± 1.6 (42) | 58.4 ± 1.6 (42) | 0.869 |
 LV–LS, % | − 13.2 ± 0.8 (41) | − 17.4 ± 0.7 (41)# | < 0.0001 | − 12.5 ± 0.6 (58) | − 11.9 ± 0.5 (58) | 0.298 |
 LV S’, cm/s | 10.5 ± 0.8 (31) | 10.6 ± 0.8 (31) | 0.581 | 10.2 ± 0.6 (65) | 10.4 ± 0.6 (65) | 0.036 |
 Pericardial effusion | 17/56 (30.4%)* | 14/49 (28.6%)* | 1.000 | 53/120 (44.2%) | 39/78 (50%) | 1.000 |